STOCK TITAN
  1. Home
  2. Sec-filings
  3. LMAT
  4. [Form 4] LEMAITRE VASCULAR INC Insider Trading Activity

LeMaitre (LMAT) SVP awarded new dividend equivalent rights grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LeMaitre Vascular Senior Vice President of Operations Trent G. Kamke reported seven acquisitions of Dividend Equivalent Rights on March 26, 2026. Each right is economically equivalent to one share of LeMaitre common stock and is tied to previously granted restricted stock unit and performance share unit awards from 2022, 2023, 2024 and 2025, vesting in step with those underlying awards. These entries reflect routine, compensation-related accruals rather than open-market trading.

Positive

  • None.

Negative

  • None.
Insider Kamke Trent G
Role Senior V. P., Operations
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights 0.694 $0.00 --
Grant/Award Dividend Equivalent Rights 0.694 $0.00 --
Grant/Award Dividend Equivalent Rights 1.187 $0.00 --
Grant/Award Dividend Equivalent Rights 1.423 $0.00 --
Grant/Award Dividend Equivalent Rights 1.592 $0.00 --
Grant/Award Dividend Equivalent Rights 1.803 $0.00 --
Grant/Award Dividend Equivalent Rights 2.667 $0.00 --
Holdings After Transaction: Dividend Equivalent Rights — 9.428 shares (Direct)
Footnotes (1)
  1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Derivative acquisitions count 7 transactions Dividend Equivalent Rights on March 26, 2026
Largest grant size 2.6670 rights Dividend Equivalent Rights acquired March 26, 2026
Smallest grant size 0.6937 rights Dividend Equivalent Rights acquired March 26, 2026
Post-transaction holding example 11.1325 rights Dividend Equivalent Rights total following one transaction
Dividend Equivalent Rights financial
"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock unit financial
"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
performance share unit financial
"These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024"
A performance share unit (PSU) is a form of executive or employee pay that promises shares (or the cash value of shares) only if the company meets specific performance targets over a set period. Think of it like a bonus cheque that only arrives if the company hits agreed goals — it aligns managers’ rewards with business results and signals to investors how leadership is being incentivized to grow value over time.
economic equivalent financial
"Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kamke Trent G
(Last)(First)(Middle)
C/O LEMAITRE VASCULAR , INC.
63 SECOND AVENUE
(Street)
BURLINGTON MASSACHUSETTS 01803
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Senior V. P., Operations
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Dividend Equivalent Rights(1)03/26/2026A0.6937 (1) (1)Common Stock0.6937$09.4277D
Dividend Equivalent Rights(2)03/26/2026A0.6937 (2) (2)Common Stock0.6937$09.4193D
Dividend Equivalent Rights(3)03/26/2026A1.187 (3) (3)Common Stock1.187$010.4633D
Dividend Equivalent Rights(4)03/26/2026A1.4229 (4) (4)Common Stock1.4229$011.1325D
Dividend Equivalent Rights(5)03/26/2026A1.5918 (5) (5)Common Stock1.5918$08.1911D
Dividend Equivalent Rights(6)03/26/2026A1.8027 (6) (6)Common Stock1.8027$08.402D
Dividend Equivalent Rights(7)03/26/2026A2.667 (7) (7)Common Stock2.667$02.667D
Explanation of Responses:
1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
/s/ Laurie A. Churchill, Attorney-in-fact03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did LeMaitre Vascular (LMAT) insider Trent Kamke report in this Form 4?

Trent G. Kamke, Senior Vice President of Operations at LeMaitre Vascular, reported seven acquisitions of dividend equivalent rights on March 26, 2026. These awards are compensation-related derivatives tied to prior restricted stock and performance share grants, not open-market stock purchases or sales.

What are dividend equivalent rights in the LeMaitre (LMAT) Form 4 filing?

Dividend equivalent rights give the holder economic value equal to LeMaitre’s common stock dividends on certain share awards. In this filing, each right is the economic equivalent of one common share and accrues on existing restricted stock unit and performance share unit awards, vesting proportionately with those awards.

How many dividend equivalent rights did the LeMaitre (LMAT) executive acquire?

The filing shows seven separate acquisitions of dividend equivalent rights by the LeMaitre executive. Individual transactions range from 0.6937 to 2.6670 rights, each linked to a specific restricted stock unit or performance share unit award granted between 2022 and 2025 and vesting over time.

Are these LeMaitre (LMAT) dividend equivalent rights open-market purchases or sales?

No. The Form 4 classifies each transaction with code "A" for grant, award, or other acquisition. The dividend equivalent rights accrued automatically on existing equity awards as part of compensation and are not open-market stock purchases or sales by the executive in the marketplace.

Which LeMaitre (LMAT) equity awards generated these dividend equivalent rights?

The dividend equivalent rights accrued on restricted stock unit and performance share unit awards granted on December 12, 2022, December 8, 2023, December 6, 2024, and December 10, 2025. Each set of rights vests proportionately with its related award, matching that award’s vesting schedule.

Does this LeMaitre (LMAT) Form 4 change the executive’s direct ownership type?

No. All reported dividend equivalent rights are classified as directly owned, indicated by the "D" ownership code. The filing does not reference any trusts, family entities, or disclaimers of beneficial ownership and shows the rights as standard direct compensation-related holdings.